Alimentary Pharmacology & Therapeutics

Review article: the modern diagnosis and management of haemochromatosis
pp. 1681-1691(11)
Author: ADAMS, P. C.

Prior chemoradiotherapy is associated with a higher life-threatening complication rate after palliative insertion of metal stents in patients with oesophageal cancer
pp. 1693-1702(10)
Authors: LECLEIRE, S.; DI FIORE, F.; BEN-SOUSSAN, E.; ANTONIETTI, M.; HELLOT, M.-F.; PAILLOT, B.; LEREBOURS, E.; DUCROTTÉ, P.; MICHEL, P.

Genetic polymorphisms of interleukin-1-beta in association with sustained response to anti-viral treatment in chronic hepatitis B in Chinese
pp. 1703-1711(9)
Authors: CHAN, H. L.-Y.; TSE, A. M.-L.; ZHANG, M.-D.; WONG, V. W.-S.; CHIM, A. M.-L.; HUI, A. Y.; SUNG, J. J.-Y.

Prescribing of acid suppressive therapy: interactions between hospital and primary care
pp. 1713-1718(6)
Authors: KRAG, A.; TEGLBJERG, L. S.; MALCHOW-MØLLER, A.; HALLAS, J.; BYTZER, P.

Effect of naproxen on gastric acid secretion and gastric pH
pp. 1719-1724(6)
Authors: RODRIGUEZ-STANLEY, S.; REDINGER, N.; MINER, P. B.

Gastro-oesophageal reflux symptoms and health-related quality of life in the adult general population – the Kalixanda study
pp. 1725-1733(9)
Authors: RONKAINEN, J.; ARO, P.; STORSKRUBB, T.; LIND, T.; BOLLING-STERNEVALD, E.; JUNGHARD, O.; TALLEY, N. J.; AGREUS, L.

Comparison of a monoclonal with a polyclonal antibody-based enzyme immunoassay stool test in diagnosing Helicobacter pylori infection before and after eradication therapy
pp. 1735-1740(6)
Authors: DOMÍNGUEZ, J.; FORNÉ, M.; BLANCO, S.; PRAT, C.; GALÍ, N.; LATORRE, I.; VIVER, J. M.; AUSINA, V.

Placebo- and paracetamol-controlled study on the efficacy and tolerability of hyoscine butylbromide in the treatment of patients with recurrent crampy abdominal pain
pp. 1741-1748(8)
Authors: MUELLER-LISSNER, S.; TYTGAT, G. N.; PAULO, L. G.; QUIGLEY, E. M. M.; BUBECK, J.; PEIL, H.; SCHAEFER, E.

Alternating bowel pattern: what do people mean?
pp. 1749-1755(7)
Authors: CHOUNG, R. S.; LOCKE, G. R.; ZINSMEISTER, A. R.; MELTON, L. J.; TALLEY, N. J.

Lamivudine response of IgM anti-HBc chronic hepatitis B patients
pp. 1757-1758(2)
Authors: Gómez-Domínguez, E.; García-Buey, L.; Gisbert, J. P.; Moreno-Otero, R.

Lamivudine response of IgM anti-HBc chronic hepatitis B: authors' reply
pp. 1758-1760(3)
Authors: Chen, J.-J.; Tsai, S.-L.

Index
pp. 1761-1781(21)